News
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 third quarter ended June 30, 2025. The Company is hosting a conference call today, August 7, 2025, ...
The 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback